Mental, neurological, and substance use (MNS) disorders are leading causes of the global burden of disease and profoundly impact the social and economic well-being of individuals and communities. The majority of people affected by MNS disorders globally do not have access to evidence-based interventions and many experience discrimination and abuses of their human rights. A United Nations General Assembly Special Session (UNGASS) is needed to focus global attention on MNS disorders as a core development issue requiring commitments to improve access to care, promote human rights, and strengthen the evidence on effective prevention and treatment
Background We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (G...
We call for the global health community, governments, donors, multilateral agencies, and other menta...
The characteristics of neurological, psychiatric, developmental and substance-use disorders in low-a...
Summary Points: Mental, neurological, and substance use (MNS) disorders are leading causes of the gl...
The burden of mental, neurological, and substance use (MNS) disorders increased by 41% between 1990 ...
The burden of mental, neurological, and substance use (MNS) disorders increased by 41% between 1990 ...
The burden of mental, neurological, and substance use (MNS) disorders increased by 41% between 1990 ...
BACKGROUND: The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial proport...
BACKGROUND:The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial proporti...
Background The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial propo...
Mental and neurological disorders (MNDs) account for a large, and growing, burden of disease in low-...
Background The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial propor-t...
In the aggregate, neurologic, psychiatric, and devel-opmental disorders (NPDDs) are the largest cont...
SummaryMental and neurological disorders (MNDs) account for a large, and growing, burden of disease ...
The 2010 Global Burden of Disease Study points to a changing landscape in which non-communicable dis...
Background We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (G...
We call for the global health community, governments, donors, multilateral agencies, and other menta...
The characteristics of neurological, psychiatric, developmental and substance-use disorders in low-a...
Summary Points: Mental, neurological, and substance use (MNS) disorders are leading causes of the gl...
The burden of mental, neurological, and substance use (MNS) disorders increased by 41% between 1990 ...
The burden of mental, neurological, and substance use (MNS) disorders increased by 41% between 1990 ...
The burden of mental, neurological, and substance use (MNS) disorders increased by 41% between 1990 ...
BACKGROUND: The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial proport...
BACKGROUND:The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial proporti...
Background The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial propo...
Mental and neurological disorders (MNDs) account for a large, and growing, burden of disease in low-...
Background The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial propor-t...
In the aggregate, neurologic, psychiatric, and devel-opmental disorders (NPDDs) are the largest cont...
SummaryMental and neurological disorders (MNDs) account for a large, and growing, burden of disease ...
The 2010 Global Burden of Disease Study points to a changing landscape in which non-communicable dis...
Background We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (G...
We call for the global health community, governments, donors, multilateral agencies, and other menta...
The characteristics of neurological, psychiatric, developmental and substance-use disorders in low-a...